{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:17:36Z","timestamp":1770841056631,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CeloNova BioSciences, Inc"},{"name":"CV Path Institute, Inc."},{"DOI":"10.13039\/100015330","name":"Max Kade Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CV Path Institute, Inc."},{"DOI":"10.13039\/100007716","name":"Banyu Life Science Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.07.181","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T00:52:18Z","timestamp":1469926338000},"page":"217-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Preclinical evaluation of a novel polyphosphazene surface modified stent"],"prefix":"10.1016","volume":"222","author":[{"given":"Tobias","family":"Koppara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoQing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Acampado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank D.","family":"Kolodgie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.07.181_bb0005","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0010","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0015","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1year results of a randomised controlled trial","volume":"380","author":"Sabate","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.05.085","article-title":"Meta-analyses of dual antiplatelet therapy following drug-eluting stent implantation: do bleeding and stent thrombosis weigh similar on mortality?","volume":"66","author":"Capodanno","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0030","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jvir.2007.12.450","article-title":"Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents","volume":"19","author":"Henn","year":"2008","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0040","first-page":"89","article-title":"Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents","volume":"32","author":"Mrowietz","year":"2005","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00270-007-9243-y","article-title":"Restenosis of the CYPHER-select, TAXUS-express, and polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model","volume":"31","author":"Radeleff","year":"2008","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.rli.0000156195.74967.47","article-title":"A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis","volume":"40","author":"Richter","year":"2005","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.rli.0000261439.90760.9d","article-title":"The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model","volume":"42","author":"Satzl","year":"2007","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jcis.1997.5238","article-title":"Plasma protein adsorption and platelet adhesion on poly","volume":"197","author":"Welle","year":"1998","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0065","unstructured":"Guide for the Care and Use of Laboratory Animals. In: Animals NRCCftUotGftCaUoL, editor. 8th edition ed: National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals; 2011."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427","article-title":"Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully Bioabsorbable drug-eluting stents","volume":"8","author":"Koppara","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0735-1097(92)90476-4","article-title":"Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model","volume":"19","author":"Schwartz","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0080","first-page":"383","article-title":"Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents","volume":"25","author":"Yazdani","year":"2013","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biomaterials.2009.09.079","article-title":"Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings","volume":"31","author":"Chin-Quee","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0090","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2015.03.029","article-title":"Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt model","volume":"8","author":"Otsuka","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcin.2013.09.006","article-title":"The EXAMINATION trial (everolimus-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction): 2-year results from a multicenter randomized controlled trial","volume":"7","author":"Sabate","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2014.04.022","article-title":"Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR","volume":"64","author":"Sarno","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0105","series-title":"Multi-link Vision Stent Vs. First-Generation Drug-Eluting Stents: Systematic Review and Meta-Analysis","author":"Testa","year":"2011"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1540-8183.2011.00672.x","article-title":"Long-term clinical outcome of thin-strut cobalt-chromium stents in the drug-eluting stent era: results of the COBALT (comparison of bare-metal stents in all-comers' lesion treatment) registry","volume":"24","author":"Abdel-Wahab","year":"2011","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2217\/ica.11.34","article-title":"The rapid evaluation of vessel healing after angioplasty (REVEAL) trial","volume":"3","author":"Tamburino","year":"2011","journal-title":"Interv. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0125","first-page":"1373","article-title":"Preclinical restenosis models and drug-eluting stents: still important, still much to learn","volume":"44","author":"Schwartz","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0130","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1161\/01.CIR.0000038984.30279.89","article-title":"Coated stents for the prevention of restenosis: part II","volume":"106","author":"Babapulle","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0135","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00270-008-9392-7","article-title":"Reduction of late in-stent stenosis in a porcine coronary artery model by cobalt chromium stents with a nanocoat of polyphosphazene (Polyzene-F)","volume":"31","author":"Stampfl","year":"2008","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1253\/circj.72.463","article-title":"Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis","volume":"72","author":"Lim","year":"2008","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcin.2012.12.131","article-title":"Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice","volume":"6","author":"Farooq","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.107.730010","article-title":"Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries","volume":"120","author":"Wilson","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0155","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9149(03)00717-3","article-title":"Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines","volume":"92","author":"Georges","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0160","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1601","article-title":"Mast cells promote atherosclerosis by releasing proinflammatory cytokines","volume":"13","author":"Sun","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0165","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1161\/CIRCULATIONAHA.104.510073","article-title":"Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody","volume":"111","author":"Lutgens","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02977462","article-title":"Role of interleukin-4 in atherosclerosis","volume":"29","author":"Lee","year":"2006","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.19.3.611","article-title":"Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death","volume":"19","author":"Mallat","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0185","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0190","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1172\/JCI118650","article-title":"Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis","volume":"97","author":"Uyemura","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0195","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/01.CIR.91.12.2995","article-title":"Endovascular stent design dictates experimental restenosis and thrombosis","volume":"91","author":"Rogers","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0200","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","article-title":"Morphological predictors of restenosis after coronary stenting in humans","volume":"105","author":"Farb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00062752-200109000-00001","article-title":"Platelets, leukocytes, and coagulation","volume":"8","author":"Bouchard","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0210","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/S0142-9612(02)00030-3","article-title":"Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model","volume":"23","author":"Thierry","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijcard.2016.07.181_bb0215","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2013.07.106","article-title":"Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5Years: synergy between percutaneous coronary intervention with Taxus and cardiac surgery trial","volume":"62","author":"Farooq","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.181_bb0220","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ccd.21834","article-title":"Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces","volume":"73","author":"Hansi","year":"2009","journal-title":"Catheter. Cardiovasc. Interv."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316315765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316315765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:25:06Z","timestamp":1589682306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316315765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":44,"alternative-id":["S0167527316315765"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.181","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of a novel polyphosphazene surface modified stent","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}